HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does uremia interfere with HbA1c results in the FPLC method with Mono S cation exchanger?

Abstract
To study the effect of uremia on hemoglobin A1c determination by the Mono S FPLC method, samples from uremic patients, with and without diabetes, and controls, were analysed with a modified chromatography with enhanced resolution. Besides specific HbA1c, four minor peaks could be seen, included in routine HbA1c values. Two of these differed in concentration in the patient groups studied: a shoulder-like peak close to the specific HbA1c (S fraction) and a slightly less cationic minor peak (M fraction). Both S and M peaks were higher in uremic than in nonuremic subjects, but the M peak was associated more with diabetes. In the nondiabetic group, the mean routine HbA1c value was 0.8% units higher in uremic than nonuremic individuals. The specific HbA1c was nondependent on uremia. Thus, in uremic patients, there seems to be falsely elevated HbA1c values, mainly because of small interfering hemoglobin fractions, not specific HbA1c.
AuthorsL K Koskinen, I O Ala-Houhala, J T Lahtela, P J Laippala, T A Koivula
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 273 Issue 1 Pg. 69-79 (May 08 1998) ISSN: 0009-8981 [Print] Netherlands
PMID9620471 (Publication Type: Journal Article)
Chemical References
  • Cation Exchange Resins
  • Glycated Hemoglobin A
Topics
  • Adult
  • Aged
  • Artifacts
  • Cation Exchange Resins
  • Chromatography, Ion Exchange (methods)
  • Diabetes Complications
  • Diabetes Mellitus (blood)
  • Glycated Hemoglobin (analysis)
  • Humans
  • Middle Aged
  • Uremia (blood, complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: